Water-Soluble Realgar Solid Dispersion for Anemia Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inducing erythroid differentiation of bone marrow hematopoietic stem and progenitor cells to address anemia caused by blocked differentiation are limited by severe toxic side effects, particularly with recombinant human erythropoietin.
Innovation Solution
A water-soluble realgar solid dispersion is developed, comprising refined realgar (As4S4) combined with amphiphilic polymers and surfactants, which forms stable nanoparticles that rapidly disintegrate in water, enhancing bioavailability and reducing toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If recombinant human erythropoietin (EPO) is used to induce erythroid differentiation of bone marrow hematopoietic cells, then erythrocyte production increases and anemia is relieved, but severe toxic side effects occur
Solution Approach 1:
The patent uses realgar (As4S4) as an intermediary substance to induce erythroid differentiation of bone marrow hematopoietic cells. Realgar acts as a mediator that triggers the differentiation process through its arsenic content, which interacts with cellular signaling pathways to promote erythroid lineage commitment, thereby achieving therapeutic effect while avoiding the severe toxicity of EPO
Solution Approach 2:
The patent changes the chemical parameter by using arsenic-containing realgar instead of protein-based EPO. This parameter change from a biological molecule to a small inorganic compound with different molecular weight, solubility, and metabolic pathways results in reduced toxic side effects while maintaining the ability to induce erythroid differentiation
2Object-affected harmful factors
If realgar is used to induce erythroid differentiation, then toxic side effects are reduced, but water solubility and bioavailability are insufficient
Solution Approach 1:
The patent creates a composite material system by combining realgar (As4S4) with amphiphilic polymers and surfactants. This composite structure forms a solid dispersion where realgar particles are dispersed within a polymer matrix that contains both hydrophilic and hydrophobic regions, enabling the hydrophobic realgar to achieve water solubility while maintaining its therapeutic activity and reduced toxicity profile
3Ease of operation
If realgar is used as solid dispersion, then water solubility improves, but manufacturing complexity increases
Solution Approach 1:
The patent simplifies the manufacturing process by changing the physical parameter of realgar from bulk solid to fine powder with controlled particle size (20-75 μm). This parameter change enables direct mixing with polymers and surfactants to form solid dispersions, avoiding complex nano-encapsulation or emulsification processes while achieving adequate water solubility enhancement
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dispersion effectively induces erythroid differentiation in bone marrow cells, increasing erythrocyte production with lower doses, thereby alleviating anemia and minimizing systemic side effects.
Implementation Method 1
a water-soluble realgar solid dispersion, comprising refined realgar (As4S4) combined with amphiphilic polymers and surfactants, which forms stable nanoparticles that rapidly disintegrate in water
Implementation Method 2
The solid dispersion can rapidly disintegrate in water to form stable yellow colloidal solution that contains realgar nanoparticles encapsulated by the polymer
Implementation Method 3
form stable yellow colloidal solution that contains realgar nanoparticles encapsulated by the polymer
Implementation Method 4
The polymer was selected from amphiphilic polymers, specifically one or more of the followings: polyethylene glycol-polyvinyl alcohol graft copolymer, polyvinyl pyrrolidone (PVP), cross-linked polyvinylpyrrolidone (PVPP)
Implementation Method 5
The surfactant is selected from one or more of the followings: polysorbate 20, polysorbate 60, polysorbate 80, sodium dodecyl sulfate, polyethylene glycol cetostearyl ether and sodium cetostearyl sulfate
Data Source
AI summary
Disclosed is the use of a water-soluble realgar solid dispersion in the preparation of an erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells. The water-soluble realgar solid dispersion is prepared from raw materials comprising 1 part by weight of realgar, 1-20 parts by weight of a polymer, and 0-5 parts by weight of a surfactant. The water-soluble realgar solid dispersion can induce bone marrow hematopoietic stem and/or progenitor cells to be differentiated into red blood cells, promote the accumulation of red blood cells in bone marrow cells, effectively alleviate the decrease in the number of red blood cells caused by the suppression of the erythroid differentiation of bone marrow hematopoietic stem and/or progenitor cells, improve anemia caused by hematopoietic failure, and protect bone marrow cells from the killing effect.